TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00071097
Recruitment Status : Completed
First Posted : October 15, 2003
Last Update Posted : September 20, 2016
Information provided by (Responsible Party):
Tibotec Pharmaceuticals, Ireland